Lytix Biopharma: Interview with CEO Øystein Rekdal
Research Interview
2024-08-15
07:15
Redeye interviews Lytix Biopharma's CEO, Øystein Rekdal, about the positive phase II readout in basal cell carcinoma.
RR
Richard Ramanius
Disclosures and disclaimers